Skip to main content
. 2024 Feb 7;15:1260191. doi: 10.3389/fimmu.2024.1260191

Figure 3.

Figure 3

Overview of the genomic mutation spectrum. (A) Overview of the genomic mutation spectrum and pathway alterations in the WES cohort (responders, n=10; non-responders, n=12); (B–D) TMB status presented no significant correlations with ORR, intrahepatic PFS, and OS; defined by median split.